Figure 5.1 – Hepatitis B & Hepatitis C Rates 18–40 Years

What to know

These figures represent the number of reported cases and estimated infections among persons aged 18–40 years for acute hepatitis B and acute hepatitis C for the years 2015–2022. Persons aged 18–40 years were used as a proxy for persons who inject drugs.
2022 Hepatitis Surveillance Appendix

Number of reported cases (Panel A) and estimated infections (Panel B) of acute hepatitis B and acute hepatitis C among adults aged 18–40 years old — United States, 2015–2022

Source: CDC, National Notifiable Diseases Surveillance System.

Summary

The number of reported cases and estimated infections among persons aged 18–40 years for acute hepatitis B and acute hepatitis C for the years 2015–2022. Persons aged 18–40 years were used as a proxy for persons who inject drugs.